P. Brouqui

825 total citations
45 papers, 536 citations indexed

About

P. Brouqui is a scholar working on Infectious Diseases, Parasitology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, P. Brouqui has authored 45 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 13 papers in Parasitology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in P. Brouqui's work include Vector-borne infectious diseases (12 papers), COVID-19 Clinical Research Studies (7 papers) and Viral Infections and Vectors (7 papers). P. Brouqui is often cited by papers focused on Vector-borne infectious diseases (12 papers), COVID-19 Clinical Research Studies (7 papers) and Viral Infections and Vectors (7 papers). P. Brouqui collaborates with scholars based in France, Ivory Coast and Zimbabwe. P. Brouqui's co-authors include Didier Raoult, B Faugère, Philippe Parola, Jean‐Christophe Lagier, Matthieu Million, Philippe Gautret, L. Matthewman, M F Saron, Andréas Stein and J Delmont and has published in prestigious journals such as Clinical Infectious Diseases, Clinical Microbiology and Infection and BMJ Open.

In The Last Decade

P. Brouqui

41 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Brouqui France 12 380 262 124 101 83 45 536
Gijs Limonard Netherlands 9 269 0.7× 385 1.5× 191 1.5× 120 1.2× 63 0.8× 17 556
Hélio Autran de Morais United States 11 266 0.7× 297 1.1× 70 0.6× 78 0.8× 65 0.8× 29 517
Edyta Podsiadły Poland 13 311 0.8× 288 1.1× 51 0.4× 69 0.7× 112 1.3× 51 532
TJ Marrie Canada 3 345 0.9× 500 1.9× 204 1.6× 164 1.6× 94 1.1× 3 593
Yumiko Furuya Japan 13 351 0.9× 520 2.0× 277 2.2× 128 1.3× 68 0.8× 30 781
Daniel Christmann France 14 391 1.0× 212 0.8× 151 1.2× 44 0.4× 168 2.0× 24 652
Monika Halánová Slovakia 18 289 0.8× 494 1.9× 44 0.4× 52 0.5× 114 1.4× 60 757
L. Čisláková Slovakia 13 195 0.5× 349 1.3× 39 0.3× 92 0.9× 57 0.7× 51 502
Sophie Edouard France 12 315 0.8× 346 1.3× 228 1.8× 67 0.7× 180 2.2× 38 663
Kye‐Hyung Kim South Korea 15 401 1.1× 90 0.3× 78 0.6× 82 0.8× 160 1.9× 41 560

Countries citing papers authored by P. Brouqui

Since Specialization
Citations

This map shows the geographic impact of P. Brouqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Brouqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Brouqui more than expected).

Fields of papers citing papers by P. Brouqui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Brouqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Brouqui. The network helps show where P. Brouqui may publish in the future.

Co-authorship network of co-authors of P. Brouqui

This figure shows the co-authorship network connecting the top 25 collaborators of P. Brouqui. A scholar is included among the top collaborators of P. Brouqui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Brouqui. P. Brouqui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Nhu Ngoc, Hervé Tissot‐Dupont, P. Brouqui, & Philippe Gautret. (2025). Post-COVID syndrome in symptomatic COVID-19 patients: a retrospective cohort study. BMC Infectious Diseases. 25(1). 1099–1099. 1 indexed citations
2.
Brouqui, P., Éric Chabrière, & Didier Raoult. (2024). Hydroxychloroquine: Pharmacokinetics and Toxicity. Journal of Clinical Pharmacy and Therapeutics. 2024(1). 2 indexed citations
3.
Million, Matthieu, Jean‐Christophe Lagier, Jérôme Hourdain, et al.. (2023). Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients. Medicina. 59(5). 863–863. 1 indexed citations
4.
Meddeb, Line, et al.. (2023). Pre-Hospital Management of Patients with COVID-19 and the Impact on Hospitalization. Medicina. 59(8). 1440–1440.
5.
Brouqui, P., Michel Drancourt, & Didier Raoult. (2023). There is no such thing as a Ministry of Truth and why it is important to challenge conventional “wisdom” - A personal view. New Microbes and New Infections. 54. 101155–101155. 1 indexed citations
6.
Brouqui, P., Matthieu Million, Philippe Parola, Peter A. McCullough, & Didier Raoult. (2023). Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients. New Microbes and New Infections. 55. 101188–101188. 4 indexed citations
7.
Brouqui, P., Philippe Colson, Cléa Melenotte, et al.. (2021). EXPRESSION OF CONCERN: COVID‐19 re‐infection. European Journal of Clinical Investigation. 51(5). e13537–e13537. 41 indexed citations
8.
Dubourg, G, Jean‐Christophe Lagier, P. Brouqui, et al.. (2021). Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?. Journal of Microbiology Immunology and Infection. 54(5). 997–1000. 15 indexed citations
9.
Lagier, Jean‐Christophe, Marion Delord, Matthieu Million, et al.. (2015). Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report. European Journal of Clinical Microbiology & Infectious Diseases. 34(8). 1597–1601. 42 indexed citations
10.
Million, Matthieu, et al.. (2013). Macrophage activation syndrome associated with co-trimoxazole. Médecine et Maladies Infectieuses. 43(3). 128–130. 3 indexed citations
11.
Benkouiten, Samir, Philippe Gautret, Khadidja Belhouchat, et al.. (2013). Acquisition of Streptococcus pneumoniae Carriage in Pilgrims During the 2012 Hajj. Clinical Infectious Diseases. 58(4). e106–e109. 38 indexed citations
12.
Brouqui, P., et al.. (2012). Interferon-gamma release assay: use and misuse. Clinical Microbiology and Infection. 18(11). 1053–1054. 1 indexed citations
13.
Doudier, Barbara, et al.. (2010). Leptospirosis diagnosed by molecular DNA detection on skin biopsy. BMJ Case Reports. 2010. bcr0920092313–bcr0920092313. 1 indexed citations
14.
Boni, Mickaël, et al.. (2009). Isolated fever in horses: a new case of equine anaplasmosis in France. Clinical Microbiology and Infection. 15. 64–65. 5 indexed citations
15.
Badiaga, Sékéné, et al.. (2008). Cas pour diagnostic. 12(2). 2 indexed citations
16.
Botelho-Nevers, Élisabeth, Cédric Foucault, Hubert Lépidi, & P. Brouqui. (2005). Cerebral infarction: An unusual complication of Mediterranean spotted fever. European Journal of Internal Medicine. 16(7). 525–527. 10 indexed citations
17.
Niang, M., et al.. (1998). Des lésions nodulaires douloureuses. La Revue de Médecine Interne. 19(9). 670–671. 1 indexed citations
18.
Brouqui, P., et al.. (1995). Prevalence of Antibodies to Coxiella burnetii, Rickettsia conorii, and Rickettsia typhi in Seven African Countries. Clinical Infectious Diseases. 21(5). 1126–1133. 121 indexed citations
19.
Kelly, Patrick, L. Matthewman, Suman M. Mahan, et al.. (1994). Serological evidence for antigenic relationships between Ehrlichia canis and Cowdria ruminantium. Research in Veterinary Science. 56(2). 170–174. 35 indexed citations
20.
Brouqui, P., Patrick Kelly, A. Tounkara, et al.. (1994). Serologic evidence for human ehrlichiosis in Africa. European Journal of Epidemiology. 10(6). 695–698. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026